fda announcement tirzepatide approves (Zepbound) injection for chronic weight management, with 72-week trials showing statistically significant body-weight reduction in adults with obesity or overweight FDA Drops Latest Statement: Tirzepatide

Designed for vegans, sensitive individuals, and adults seeking weight management, simply take two capsules 30 minutes before lunch daily

A once-weekly injectable glucose-dependent insulinotropic polypeptide/GLP-1 dual agonist conferred up to 14.7% weight loss at 13 weeks for adults with overweight or obesity, according to findings from the VENTURE trial published in Obesity

Find out how to secure a 5-month supply, explore sublingual alternatives, and stay ahead of the changes.

Learn about the risks, side effects, and effectiveness of combining these weight loss treatments.

Consultant Internal Medicine Qatar Key Points to Note When Using GLP-1 Analogues in Qatar Wellkins Medical Centre